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Pillar cellceptor 3 (FGFR3) is a key regulator of skeletal development and activating
mutations in FGFR3 cause skeletal dysplasias, including hypochondroplasia, achondroplasia and thanato-
phoric dysplasia. The introduction of the Y367C mutation corresponding to the human Y373C thanatophoric
dysplasia type I (TDI) mutation into the mouse genome, resulted in dwarﬁsm with a skeletal phenotype
remarkably similar to that of human chondrodysplasia. To investigate the role of the activating Fgfr3 Y367C
mutation in auditory function, the middle and inner ear of the heterozygous mutant Fgfr3Y367C/+ mice were
examined. The mutant Fgfr3Y367C/+ mice exhibit fully penetrant deafness with a signiﬁcantly elevated
auditory brainstem response threshold for all frequencies tested. The inner ear defect is mainly associated
with an increased number of pillar cells or modiﬁed supporting cells in the organ of Corti. Hearing loss in the
Fgfr3Y367C/+ mouse model demonstrates the crucial role of Fgfr3 in the development of the inner ear and
provides novel insight on the biological consequences of FGFR3 mutations in chondrodysplasia.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Fibroblast growth factors (FGFs) and their surface receptors
regulate a variety of cellular processes during embryonic and
postnatal development. Four ﬁbroblast growth factor receptors
(FGFRs) are known, and three of them are associated with genetic
disorders in humans [1]. Among them, FGFR3 has been recognized as a
critical regulator of endochondral bone growth. Mutations in the
coding sequence of the FGFR3 gene have been shown to cause
achondroplasia (ACH), the most common form of dwarﬁsm [2],
hypochondroplasia (HCH), a milder phenotype [3] and thanatophoric
dysplasia (TD), the most severe form of dwarﬁsm [4,5]. All FGFR3
mutations examined so far result in a ligand-independent phosphory-
lation of the tyrosine kinase domain [6]. To further study the function
of FGFR3 during development, several mouse models have been
created with various mutations corresponding to ACH or TD
phenotypes [7–13]. The different mouse models displayed varying
degrees of disproportionate dwarﬁsm with skeletal anomalies. By
contrast, the mouse model lacking Fgfr3 had skeletal overgrowth, thisfax: +33 147348514.
Legeai-Mallet).
ll rights reserved.growth is accompanied by expansion of the proliferating and
hypertrophic chondrocytes within the growth plate [14–16].
In vertebrates, the perception of sounds is controlled by epithelial
sensory cells located in the cochlear region of the inner ear. The
sensory epithelium forms the organ of Corti which mediates the
auditory function in mammals and comprises distinct cell types
arranged in precise rows that extend along the entire length of the
cochlear spiral. The organ of Corti contains one row of inner and three
rows of outer hair cells and several types of supporting cells, namely
pillar cells, Deiter's cells, Hensen's and Claudius' cells [17]. Previous
studies have demonstrated that Fgfr3 is required for pillar cell
development and an increase in the number of both outer hair cells
and Deiter's cells was recently observed in the cochleae of Fgfr3 knock
out mice [16]. In these mice, a signiﬁcant hearing loss was found to be
due to cochlear impairment. The cochlear defect consisted of a lack of
differentiation and an incomplete development of pillar cells within
the organ of Corti [14–16]. In contrast, ectopic activation of Fgfr3 by
either the FGF2 or FGF8 in cochlear explants induces an over-
expression of pillar cells in the organ of Corti [18,19]. In addition, both
Spry2 null mutants [20] andMuenkemodel mice (Fgfr3P244R/+) [21] are
hearing impairment and an excess of pillar cell development.
To investigate the impact of a constitutive activation of Fgfr3 on
cochlear development, we generated a mouse model carrying the
heterozygous Y367C mutation corresponding to the human Y373C
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of FGFR3 in vitro [22]. Here, we show for the ﬁrst time, that the
heterozygous mutant mice (Fgfr3Y367C/+) exhibited a penetrant inner
ear defect with a signiﬁcantly elevated auditory brainstem response
threshold in addition to severe dwarﬁsm. Histological studies of the
organ of Corti revealed an increased number of cells with the
appearance of pillar cells most likely derived from Deiter's cells; we
called these cells “modiﬁed Deiter's cells”. Hearing loss in the
Fgfr3Y367C/+ mouse emphasizes the interest in addressing the role of
FGFR3 in the development of the organ of Corti.
2. Materials and methods
2.1. Generation of Fgfr3Y367C/+ mice
The mutant construction was generated by PCR ampliﬁcation of
mouse 129 Sv/Pas genomic DNA. The Y367C mutationwas introduced
into exon 9 of the mouse Fgfr3 gene using oligonucleotides ﬂanking
the targeted sequence. The 468 bp PCR product containing the
mutation was cloned upstream of a NEO cassette ﬂanked by LoxP
recombination sites (ICS vector). Two fragments of 4.1 and 2.1 kb
respectively, were added as 5′ and 3′ homology arms. An Fse I
restriction site was added in intron 8 for cloning purposes (−175 from
exon 9) (Fig. 1A). The construct was linearized by digestion of the
polylinker upstream of the 5′ homology arm and electroporated in
129 Sv/Pas mouse ES cells (ICS cell line). Genomic DNA from ES cell
clones was digested with restriction enzymes and subjected to
Southern blot analysis with either a 3′ external probe or a NEO
probe (Fig. 1B). The presence of the mutation in the recombinant
clones was conﬁrmed by sequencing using oligonucleotides to the
NEO cassette. The 129 Sv/Pas mice exhibiting germ-line transmission
of the Y367C mutation were crossed with CMV-Cre mice (C57BL/6j)
[23] in order to delete the NEO gene. Genotypes of the resulting
offspring were determined by PCR analysis using primers 1 (5′
GATACCAGGTTTTGAGCTCCCTGTCC-3′) and 2 (5′TCAAGCCTATGAGG-
CAAG GTGTGG-3′). All animal studies were conducted according to an
Animal study protocol approved by the animal Care and Use Committee.
2.2. Radiographs, microradiographs and scanners
Animals from a mixed background (C57BL/6j/129 Sv/Pas) were
studied at birth (P0) and at ﬁve time points (P7, P14, P21, P28 and P35).
All animals were euthanized by asphyxiation in CO2. The skeletons
were visualised on Kodak oncology ﬁlms using a Cabinet X-ray System
(Faxitron series-Hewlett Packard) (15 s, 35 kV and 3 mA). The heads
were visualised on high Resolution Film SO-343 (Kodak Professional,
Paris, France) using a microfocal X-ray generator (Tubix, Paris, France)
at a focal distance of 56 cm for 20min (power setting 12mAand 15 kV).
Temporal boneswere analysedusing amicro-CTscanner (Skycan 1076:
Skycan, Antwerp, Belgium). The X-ray source was set at 55 kV and
179 μA, with a 0.5 mm aluminium ﬁlter and a pixel size at 17.60 μm.
2.3. Bone and cartilage stain
Three Fgfr3Y367C/+ and their wild type mice at P7, P14 and P21 were
studied. After removing skin, muscles and other soft tissues, the bones
and heads were ﬁxed in 95% ethanol and then stained with Alizarin
Red and Alcian Blue, cleared by KOH treatment, and stored in glycerol
according to standard protocols [24]. After several weeks, the heads
were dissected and the three ossicles (malleus, incus and stapes) were
isolated from the middle ear.
2.4. General testing procedure for auditory brainstem responses (ABRs)
Animals from 6 different litters were tested. Eight Fgfr3Y367C/+ and
their control (WT) mice were tested, at a mean age of 4 weeks (3–5 weeks). Each Fgfr3Y367C/+ mouse was tested with its WT control from
the same litter. All recording sessions and data analysis were
performed as described by Ouagazzal et al. [25]. All experimental
procedures were carried out according to European Union guidelines
and were approved by the local Ethical Committee (CREMEAS).
2.5. Histological and immunohistological analyses
Femurs and isolated cochleae from four Fgfr3Y367C/+ and their
control mice at P7, P14 and P21 were studied. Histological sections
were prepared from selected tissues that were ﬁxed in 4% para-
formaldehyde, decalciﬁed with 0.5 M EDTA and parafﬁn
embedded. Femur sections (4 μm) and cochlear sections (5 μm)
were stained with hematoxylin–eosin. For immunoﬂuorescence,
sections were blocked in PBST (PBS, 5% normal sheep serum, 0.1%
Tween) and incubated with primary antibodies overnight at 4 °C.
After washing, sections were incubated with a ﬂuorescence
labelled secondary antibody. The primary antibody, an anti p75
nerve growth factor (p75NGFR) polyclonal antibody, was purchased
from Chemicon and used at a dilution of 1/200. The labelled
secondary antibody, Alexa ﬂuor 568 goat anti rabbit antibody was
purchased from Molecular Probes and used at a dilution of 1/250.
Alexa ﬂuor 488 Phalloidin (Molecular Probes) was used at a
dilution of 1/50. Slides were mounted using Vectashield mounting
medium with DAPI (Vector). An Olympus PD70-IX2-UCB micro-
scope was used for reﬂected light ﬂuorescence and transmitted
light examination.
2.6. Ultrastructural analyses
After physiological testing, eight mutant mice and their controls
were decapitated and the inner ears were removed and ﬁxed by
immersion in 2.5% paraformaldehyde and 2.5% glutaraldehyde in
cacodylate buffer (0.1 M, pH 7.2) overnight at 4 °C. The inner ears
were decalciﬁed in 10% EDTA, dehydrated and then washed in
cacodylate buffer for a further 30 min followed by post-ﬁxation with
1% osmium tetroxide in 0.1 M cacodylate buffer for 1 h at room
temperature. The specimens were dehydrated through graded
alcohol series and embedded in Epon 812. Semi-thin serial sections
were cut at 2.5 μm (Leica ultracut UCT), stained with Toluidine Blue
and observed under a light microscope (Leitz). Transmission electron
microscopy observation was performed with a Morgagni microscope
(FEI) and pictures were processed with the Adobe Photoshop
(version 7) software.
3. Results
3.1. Severe dwarﬁsm in heterozygous Fgfr3Y367C/+ mice
To study the effect of FGFR3 mutations on the development of the
skeletal and auditory system, we introduced the Y367C mutation
corresponding to the human TDI mutation into the mouse genome
(Fig. 1A). Germline transmission was conﬁrmed in targeted ES cells
(Fig. 1B). The Fgfr3neoY367C/+ mice were crossed with CMV-CRE mice to
excise the NEO sequence from the germline. The Fgfr3Y367C/+ mice
were obtained with an expected Mendelian segregation. At P0,
Fgfr3Y367C/+ mice exhibited skeletal dysplasia. The phenotype became
progressively more pronounced as the mice got older, bowed tibia,
ﬁbula, ulna and radius were observed in all Fgfr3Y367C/+ mice at age of
3 weeks. The mutant mice exhibited a reduced length of long bone
especially femur and tail bones, a narrow trunk, short ribs and
macrocephaly (Fig. 1C), they died 6–8 weeks after birth. Histological
examination of epiphyseal growth plates in Fgfr3Y367C/+ mice showed
that the growth plate was disorganized, the chondrocyte columns
were markedly shortened and hypertrophic chondrocytes were
reduced in number and size (Fig. 1D). All these observations showed
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Fig. 2. Auditory deﬁcits in Fgfr3Y367C/+ mice. Auditory Brainstem Response (ABR)
thresholds from 8 Fgfr3Y367C/+mice (red line) and 8WTmice (blue line) at a mean age of
4 weeks (3–5 weeks). The Fgfr3Y367C/+ displayed a mild deafness with an elevated ABR
threshold for frequencies between 3 to 50 kHz. Vertical bars indicate S.E.M.
Fig. 3. Analysis of the middle and inner ear. (A) Microradiograph of the skull of the
Fgfr3Y367C/+ mouse at P14 showing a dome-shaped skull, a shortened cranial base, a
hypoplastic midface, a prognathic mandible (Md), an abnormal orientation of the semi
circular canals (SCC), cochlea (Co) and foramen magnum (Fm) in the temporal bone. (B)
High resolution computed tomography (HRCT) scanning reveals a normal cochlea (Co),
vestibule (Ve) and internal acoustic meatus (IAM) in both WT and Fgfr3Y367C/+ mice at
P21. The temporal bone (TB) is poorly developed in Fgfr3Y367C/+ mice. (C) Three
dimensional (3D) images of the bony labyrinth which consist of the vestibule (Ve), the
semi circular canals (SCC) and the cochlea (Co) with the oval window (OW) and round
window (RW) in 3 week-old Fgfr3Y367C/+ and WT mice. (D) Staining of the bony capsule
of the inner ear and the ossicles from the middle ear shows delayed ossiﬁcation in the
bony capsule of the Fgfr3Y367C/+ mice at P0. Ossiﬁcation of the cochlea (Co) was delayed
in Fgfr3Y367C/+mice. At P7, the orbicular apophysis of the malleus (Ma) (arrow), the incus
(In) and the stapes (St) were still cartilaginous in the Fgfr3Y367C/+mice. Oneweek later, at
P14, the ossicles were slightly delayed in Fgfr3Y367C/+ mice and totally ossiﬁed in WT.
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dysplasia in mice.
3.2. Auditory brainstem responses (ABRs) of Fgfr3Y367C/+ mice
The auditory thresholds of eight Fgfr3Y367C/+ and wild type (WT)
mice was assessed at a mean age of 4 weeks using ABRs. All WT mice
exhibited normal ABR waveforms and thresholds, although threshold
variability was high as shown by the standard error of themean (SEM)
values ascribed to the age at testing. The Fgfr3Y367C/+ mice displayed a
signiﬁcantly higher ABR threshold for frequencies between 3 to
50 kHz (two-way ANOVA), [F(1.6)=235.8, pb0.0001], with a maxi-
mumof 50 dB for themedium range frequencies, and around 30 dB for
lower and higher frequencies indicating a mild hearing loss (Fig. 2).
The penetrance of the disease was complete, the hearing loss was
dominant on the genetic background studied.
3.3. Imaging analysis
To investigate the bases of auditory defects in Fgfr3Y367C/+ mice,
we examined the skull, the middle ear and the inner ear. The skull
of Fgfr3Y367C/+ mice was markedly reduced in size along the
anteroposterior axis whereas the left–right and dorsal–ventral axes
were only slightly increased compared to WT mice. Radiographs of
Fgfr3Y367C/+ mice showed a dome-shaped skull, with a shortened
skull base, an hypoplastic midface, a prognathic mandible and an
abnormal orientation of the temporal bone (Fig. 3A). Four
Fgfr3Y367C/+ and their WT mice were analysed using temporal
bone high-resolution computed tomography (HRCT). On axial
views, the petrous part of the temporal bone of the Fgfr3Y367C/+
mice appeared similar to WT mice during postnatal development.Fig. 1. Generation of the dwarf Fgfr3Y367C/+ mouse. (A) The point mutation Y367C in mouse ex
9 through homologous recombination in ES cells. Once germ-line transmission was establis
Identiﬁcation of ES cells and mice carrying the Fgfr3Y367C/+ allele by Southern blot followin
Fgfr3Y367C/+ (right) and wild type (WT) littermatemice (left). Note the narrow trunk, short ribs
femur from Fgfr3Y367C/+ and WT mice at age of 3 weeks. The growth plate in the mutant m
compared to control.The computed tomography (CT) scanners showed normal cochlea,
vestibule and internal acoustic meatus (Fig. 3B). There was no
obvious change in size or shape of the ossicles, nor abnormality of
the incudomallear joint, incudostapedial joint, or stapes and ovalon 9 was co-transferred with the neomycin gene (NEO) ﬂanked by LoxP sites, into intron
hed, Fgfr3neoY367C/+ mice were crossed with CMV-Cre mice to remove the NEO gene. (B)
g digestion of genomic DNA with Bam HI and Hind III. (C) Radiographs in 3 week-old
and long bones, andmacrocephaly in the Fgfr3Y367C/+mouse. (D) Histological sections of
ice is severely disorganized with a reduced hypertrophic zone in the cartilage (arrow)
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temporal bone corresponding to the human mastoid was poorly
developed with low pneumatization in all the Fgfr3Y367C/+ mice.Fig. 4. Modiﬁcations of the organ of Corti in Fgfr3Y367C/+ mice. (A) Cross-sections of the ﬁr
phalloidin (green), DAPI (blue) and p75NGFR (red). The mutant and WT mice presented a nor
three outer hair cells (OHC) and three Deiter's cells (DC). (B) Schematic drawing of cross-sectio
composed of pillar cells (PC) (orange), Deiter's cells (DC) (red), inner hair cells (IHC) and ou
mice at P7 showing the same number of cells as seen at birth in the WT mice, except for the
Deiter's cells (DC). (D) Cross-sections through the organ of Corti at P14, stained for phalloidi
Fgfr3Y367C/+mice and large spaces are visible between rows of outer hair cells (OHC) (asterisks
Note the presence of two modi ﬁed Deiter's cells (MDC) (red) and large spaces (asterisk s)Finally, the foramen magnum was displaced anteriorly as a result
of the shortened skull base. Conventional two-dimensional (2D)
imaging was used to study ossicles and inner ear structures of thest turn of the cochlear canal through the organ of Corti (OC) at P0 were stained with
mal number of cells in the organ of Corti: one inner hair cell (IHC), two pillar cells (PC),
nal views of the organ of Corti in theWTand Fgfr3Y367C/+mice at P0. The organ of Corti is
ter hair cells (OHC) (green). (C) Cross-sections through the organ of Corti of Fgfr3Y367C/+
presence of four outer hair cells (OHC) in this case. P75NGFR labels pillar cells (PC) and
n and counterstained with DAPI. Two modiﬁed Deiter's cells (MDC) were present in the
). (E) Schematic drawing of the mature organ of Corti inWTand Fgfr3Y367C/+mice at P14.
 between outer hair cells (OHC) in the mutant mice. Magniﬁ cation × 63 (A ,C,D).
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intricate interrelationships, we used CT with three-dimensional
(3D) volume rendering (VRT). Oblique or lateral 3D images showed
similar results in Fgfr3Y367C/+ mice and WT mice during the
postnatal period (P0–P35). The cochlea had a snail shell shape,
the three canals of the cochlea winding around a central axis just
over 2 1/2 times (Fig. 3C). The vestibular organs continued
anteriorly with the cochlea and posteriorly with the semicircular
canals. The semicircular canals formed nearly two-thirds of a circle
and were enlarged anteriorly to form the ampulla. The bony
labyrinth was normal in WT and Fgfr3Y367C/+ mice (Fig. 3C).Fig. 5. Light and transmission electron micrographs (TEM) of 4 week-old Fgfr3Y367C/+ and WT
cochlear canal consists of two types of sensory cells, one row of inner hair cells (IHC) and 3 row
inner pillar (IP) and the outer pillar (OP). The inner and outer pillar nuclei are located on the b
is termed Nuel's space (NS). Each outer hair cell is supported by a Deiter's cell (DC). The effer
part of the tunnel of Corti. (B) Transmission electron micrograph at the synaptic pole from an
and the basal pole of the outer hair cells are surrounded by a Deiter's cell (DC) in WT mouse.
microtubules (mt) and outer spiral ﬁbers (osf) running in an invagination of the lateral cytop
Fgfr3Y367C/+ mouse. The inner hair cell (IHC) is separated from outer hair cells (OHC) by the tu
not supported at their basal poles by Deiter's cell (DC) but are replaced by a pillar-like s
corresponding tomedial olivocochlear ﬁbers (MOC) are visible. Spaces (asterisks) between ou
of the cochlear canal of the Fgfr3Y367C/+ mouse. Note that the outer hair cells (OHC) are free
“modiﬁed Deiter's cells” (white arrowhead) is situated close to the basilar membrane (BM).
presents a large concentration of well-oriented microtubules (mt) with reduced cytoplasmic
cytoplasm visible in boxed area b from Figure E. (H) Transmission electronmicrograph from b
the ﬁrst “modiﬁed Deiter's cell” (MDC). (I) Transmission electron micrograph from the boxe
Deiter's cells” (MDC) are in close contact with the outer hair cells (arrow heads). An outer sp
below the outer hair cells. a: afferent, e: efferent synapses. (J) Transmission electronmicrogra
several outer spiral ﬁbers (OSF). Scale bars: B, C, G, J and I: 1 μm, F: 0.5 μm, H: 5 μm.To evaluate endochondral ossiﬁcation, the three ossicles were
stained with alizarin red and alcian blue. The malleus, which is the
largest of the ossicles, lies anterolateral to the incus and stapes. A facet
on the posterior surface of the head of the malleus articulates with the
body of the incus. The anatomy of the ossicular chain in the Fgfr3Y367C/+
mice was normal. However, at P0, there was a severe ossiﬁcation
delay in the cochlea of Fgfr3Y367C/+ mice compared to WT mice (Fig.
3D). At P7, we observed that the orbicular apophysis of the malleus
was still cartilaginous in Fgfr3Y367C/+ mice whereas it was ossiﬁed in
WT mice. A similar delay was observed in the incus and the stapes
(Fig. 3D). At P14, ossiﬁcation of ossicles was complete in WT mice andcochleae. (A) Light micrograph of the ﬁrst turn of the cochlear canal of WT mouse. The
s of outer hair cells (OHC) separated by the tunnel of Corti (TC) with two pillar cells, the
ase of the basilar membrane (BM). The large open space between the IP and the ﬁrst OHC
ent ﬁbers, called medial olivocochlear ﬁbers (MOC) can be observed crossing the upper
outer hair cell (OHC) of the ﬁrst row showing two efferent synapses (e), both synapses
(C) Transmission electron micrograph of the ﬁrst Deiter's cell (DC) showing a bundle of
lasm in WT mouse. (D) Light micrograph from the ﬁrst turn of the cochlear canal from
nnel of Corti where the lumen appears smaller. The two ﬁrst rows of outer hair cells are
tructure called “modiﬁed Deiter's cells” (MDC). Upper efferent tunnel crossing ﬁbers
ter hair cells, called Nuel's space (NS), are larger. (E) Light micrograph from the ﬁrst turn
-standing in the space between the “modiﬁed Deiter's cells” (MDC). The nucleus of the
(F) Transmission electron micrographs of the boxed area a from Figure E. The ﬁrst MDC
area (ca). (G) The outer pillar (OP) is mainly composed of microtubules without much
ox c of Figure E corresponding to the ﬁrst and second rows of outer hair cells (OHC) and
d area of Figure H from the synaptic pole of the outer hair cells (OHC). The “modiﬁed
iral ﬁber (OSF) is seen in close contact with the MDC. Two synaptic contacts are visible
ph from a lateral region of the “modiﬁed Deiter's cells” (MDC) from the ﬁrst row showing
146 S. Pannier et al. / Biochimica et Biophysica Acta 1792 (2009) 140–147slightly delayed in Fgfr3Y367C/+ mice. These data are consistent with
the results found in long bones of Fgfr3Y367C/+ mice, where a severe
ossiﬁcation delay was observed at P0, P7 and P14 (data not shown).
3.4. Immunohistological studies in the cochlea
We studied the cytoarchitecture of the organ of Corti from the ﬁrst
turn of the cochlear canal. At P0 and P7, WT and Fgfr3Y367C/+ mice
presented a single row of inner hair cells (Fig. 4A and C). In addition,
three or four rows of outer hair cells and Deiter's cells were almost
consistently observed in WT and Fgfr3Y367C/+ mice (Fig. 4A and C). At
P0 and P7, no gross abnormalities were observed in the basilar and
tectorial membranes and the same number of pillar and Deiter's cells
was stained by p75NGFR, a speciﬁc marker of supporting cells in both
WT and Fgfr3Y367C/+ mice (Fig. 4B). At P14, the tunnel of Corti was well
formed by the pillar cells in the WT mice (Fig. 4D). By contrast, the
Fgfr3Y367C/+ mice displayed two ectopic pillars close to the ﬁrst two
outer hair cells in addition to the two normal pillar cells. We called
these pillars “modiﬁed Deiter's cells” because no Deiter's cells were
present at the usual place where these supporting cells are expected
to be. The presence of “modiﬁed Deiter's cells” created a larger space
between outer hair cells. Usually, the same number of outer hair cells
was present in WT and Fgfr3Y367C/+ mice (Fig. 4E).
3.5. Histological and ultrastructural analyses of the cochlea
Light microscopy of the inner cochlear canals from WT and
Fgfr3Y367C/+ mice of the same litter at mean age of 4 weeks showed
clear differences at the level of the basal cochlea up to the ﬁrst turn.
In a normal cochlea, Deiter's cells support the outer hair cells at
their basal poles and a lateral phalanx from the Deiter's cell projects
upward. The nucleus of Deiter's cell is located in the upper region of
the cell body, while the nucleus of the outer hair cells is in the basal
region of the cell body. The most obvious differences were observed
at the level of the outer hair cells and Deiter's cells. The outer hair
cells look shorter and irregularly shaped. The space between the
outer hair cells (called Nuel's space) was broader and the tunnel of
Corti presented a smaller opening in Fgfr3Y367C/+ mice (compare Fig.
5A and D–E). The two ﬁrst rows of Fgfr3Y367C/+ mice outer hair cells
are not supported at their basal poles by Deiter's cell but replaced by
a pillar-like structure called “modiﬁed Deiter's cells”. This structure
directly connected the basilar membrane to the top of the organ of
Corti at the level of the cuticular plate of the outer hair cells (Fig. 5A
and D–E). Some cellular characteristics of the “modiﬁed Deiter's
cells” were reminiscent of pillar cells, such as the number of
microtubules, although a greater number of microtubules were
fasciculated into large bundles (Fig. 5F and G). In addition, the
nucleus occupied a basal position just above the basilar membrane.
Other features tended to correspond to Deiter's cell characteristics
such as 1) the large amount of cytoplasm on either side of the pillar-
like structure (Fig. 5F and J), and 2) outer spiral ﬁbers running in an
invagination along the lateral cytoplasm (Fig. 5C and J). On the
contrary, the third outer hair cells are supported by a normal
Deiter's cell. As in WT mice, several afferent and efferent synaptic
contacts were present in the Fgfr3Y367C/+ mice (Fig. 5B and I).
Ultrastructural analyses of outer hair cells in the apical region
showed a regular cuticular plate topped with a bundle of stereocilia
(Fig. 5H). These differences were usually restricted to the basal and
ﬁrst turn of the cochlea and progressively disappeared in the upper
regions of the cochlea.
4. Discussion
Fibroblast growth factor receptor 3 plays an important role in the
normal development of the skeleton [26] and mutations in the gene
are responsible for ACH, as well as other related conditions such asTD and HCH [2–4]. Several mouse models exist in which mutations
in FGFR3 resulted in skeletal conditions that mimic the human
diseases [7–13]. Here, we report a novel mouse model of skeletal
dysplasia corresponding to the human Y373C TD mutation,
generated by introducing a Y367C point mutation into the mouse
Fgfr3 gene. The analysis of the long bones of Fgfr3Y367C/+ mice
indicated that the growth plate was disorganized with a reduced
size of the hypertrophic and proliferative zone. Hypertrophic
chondrocytes appeared smaller than WT cells and the column
arrangement was altered. The same disorganization of the growth
plate and a severe endochondral ossiﬁcation defect were observed
in human Y373C TD mutation (TDI) [27]. The Fgfr3Y367C/+ mice
displayed a narrow trunk, short limbs, a shortened skull base, a large
head with shortened nasal bone and prognathic mandible. All of
these changes result from the disruption of endochondral ossiﬁca-
tion in the long bone and at the base of the skull. According to these
data, we observed also a delayed ossicular chain and cochlear
ossiﬁcation in mutant mice at P0 and P7. We cannot exclude that
this defect of the middle ear could account for a conductive hearing
loss.
This study addresses the role of mutations in the Fgfr3 gene on
mild hearing loss and our data show a signiﬁcantly elevated ABR
threshold for all frequencies tested (pb0.0001) in Fgfr3Y367C/+ mice.
Our histological studies of Fgfr3Y367C/+ cochleae revealed a defect in
the inner ear. The architecture of the organ of Corti was modiﬁed
whereby the Deiter's cells adopted a phenotype intermediate between
pillar cells and Deiter's cells and we therefore called these cells
“modiﬁed Deiter's cells”. It is interesting to note that despite the
disorganization of the organ of Corti in the Fgfr3Y367C/+ mice,
anatomical changes were restricted to a lateral region to the tunnel
of Corti at the level of the outer hair cell region. The normal
appearance of the inner hair cells and the tunnel of Corti may explain
why the cochlea was still functioning [28].
Our results suggest that Fgfr3 is important in the differentiation
of progenitor cells into pillar cells and Deiter's cells during cochlear
development and several studies support this hypothesis. Ectopic
activation of Fgfr3 by FGF8 or FGF2 leads to the appearance of an
extra row of pillar cells in cochlear explants [18,19]. In addition,
deletion of the Spry2 gene, a negative feedback regulator of FGFRs,
causes a cochlear phenotype similar to that of the Fgfr3Y367C/+ mice.
The Spry2 null mice show extra pillar cells with a similar
morphology to the “modiﬁed Deiter's cells” observed in the
Fgfr3Y367C/+ mice [20]. Recently, a mouse model of Muenke syndrome
caused by the heterozygous Pro250Arg mutation in Fgfr3, conﬁrms
this observations, the mutant mice displays also a fully penetrant
hearing loss and an excess pillar cell development [21]. Conversely,
in a mouse model lacking Fgfr3 opposite results were observed,
namely a failure of pillar cell development and severe auditory
impairment [14–16]. During the antenatal period, Fgfr3 gene is
initially expressed in a population of cells located at the cochlear
prosensory domain, whereas at birth its expression is mainly
restricted to the pillar cells and Deiter's cells [15,16,18,19,29]. The
constitutive activation of Fgfr3 may be implicated in specifying the
fate of progenitor cells, or induce their differentiation into pillar cells
and/or Deiter's cells.
Contrary to some previous studies [18,20,21], the Fgfr3Y367C/+ mice
did not show any difference in the outer hair cells in the ﬁrst turn of
the cochlea. We hypothesize that Fgfr3 may not directly be required
for outer hair cell differentiation. It possible that Fgfr3 plays an
indirect role in regulating the differentiation of outer hair cells by
preventing a normal development of speciﬁc proteins such as Prestin
or BMPs important for the outer hair cell function [16]. Further studies
of the cytoarchitecture of the organ of Corti in Fgfr3Y367C/+ mice will
determine the exact consequences of FGF signaling during develop-
ment. These data suggest that the viable Fgfr3 model mice described
previously might also display an hearing loss [8,9,13], it will be
147S. Pannier et al. / Biochimica et Biophysica Acta 1792 (2009) 140–147interesting to study the cochlear development in these models to
conﬁrm our results.
In conclusion, the presence of extra pillar cells or “modiﬁed
Deiter's cells” in the organ of Corti in the Fgfr3Y367C/+ mice is likely to
be responsible for the observed hearing deﬁcit. In human, conductive
and sensorineural hearing loss have been reported in achondroplasia
patients [30–32], with acute otitis media and otitis media with
effusion as the most common causes of conductive hearing loss. At
present no data are available to explain the sensorineural hearing loss
in achondroplasia. The hearing loss observed in the Fgfr3Y367C/+mouse
model suggests that similar inner ear anatomical anomalies could be
present in human chondrodysplasia with activating FGFR3 mutations.
This study provides a novel insight into the biological consequences of
FGFR3 mutations, and prompts the need to pay attention to
sensorineural hearing loss in chondrodysplasia.
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